6,7,8, 9 -tetrahydro- 5h- pyrimido [4, 5-d] azepin-4-yl]...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/519 (2006.01) A61K 31/55 (2006.01) A61P 1/00 (2006.01) A61P 11/06 (2006.01) A61P 11/14 (2006.01) A61P 17/00 (2006.01) A61P 25/04 (2006.01)

Patent

CA 2646977

Certain tetrahydro-pyrimidoazepine compounds are described, which are useful as TRPV1 modulators. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by TRPV1. Thus, the compounds may be administered to treat, e.g., pain, itch, cough, asthma, or inflammatory bowel disease.

La présente invention concerne un certain nombre de composés de tétrahydro-pyrimidoazépine, qui sont utiles comme modulateurs du TRPV1. Lesdits composés peuvent être utilisés dans des compositions pharmaceutiques et des procédés permettant le traitement d'états maladifs, de troubles, et de pathologies médiés par le TRPV1. En conséquence, les composés peuvent être administrés pour traiter la douleur, le prurit, la toux, l'asthme, ou la maladie intestinale inflammatoire, entre autres.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

6,7,8, 9 -tetrahydro- 5h- pyrimido [4, 5-d] azepin-4-yl]... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 6,7,8, 9 -tetrahydro- 5h- pyrimido [4, 5-d] azepin-4-yl]..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6,7,8, 9 -tetrahydro- 5h- pyrimido [4, 5-d] azepin-4-yl]... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1764130

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.